BioWorld Science

Feb. 2, 1998

View Archived Issues

Company Profile: Alexion

Read More

Vitamin D3 analogues from Roche for skin, neoplastic diseases

Read More

BMS prepares MTP inhibitors for atherosclerosis and related diseases

Read More

Roche discloses inhibitors of bacterial dihydrofolate reductase

Read More

2,4-Diaminopyrimidines claimed as imaging agents, potentially useful in psychotic disorders

Read More

Synaptic develops selective human alpha1A-receptor antagonists

Read More

AMPA receptor antagonists disclosed by Pfizer

Read More

New anticonvulsants under study at Bristol-Myers Squibb

Read More

Somatostatin receptor ligands synthesized by Novo Nordisk

Read More

Structure of new IL-6 inhibitors determined at Kitasato Institute

Read More

Lipid peroxidation inhibitor discovered in marine sponge by team at Kirin Brewery and U. of Tokyo

Read More

OspC-based Lyme disease vaccine proves effective in animal model of chronic disease

Read More

Yamanouchi will collaborate on drug R&D with European universities

Read More

Antithrombotic agents in stroke indications

Read More

Mibefradil inhibits noradrenaline release via blockade of N-type Ca2+ channels

Read More

New wave of mergers in store for the pharmaceutical industry?

Read More

Glutamate antagonists: a new frontier in stroke research

Read More

VasoCare approved in EU

Read More

Bronchodilating and antiinflammatory effects of SCA-40 studied in vitro and in vivo

Read More

Xerecept shows promise in patients with brain tumors

Read More

Aurora sublicenses Sibia drug screening technology to Merck

Read More

RiboGene and Dainippon join forces in antibacterial collaboration

Read More

Controlled-release oxybutynin to be marketed in Europe by Synthelabo

Read More

CBER completes review of Thymoglobulin PLA

Read More

Topical interferon alfa enters phase II for intravaginal warts

Read More